Oncology News | pharmaphorum

News

David Campbell, founder, president and CEO of Janux

Janux plans $200m offer on back of prostate cancer readout

Buoyed by data from a trial of its T-cell engager (TCE) therapy in prostate cancer that almost tripled its share price, Janux Therapeutics has moved quickly to file a stoc

News

University of Southampton scientist Prof Ali Tavassoli, who is Curve's chief scientific officer

UK biotech Curve swings £40.5m in Pfizer-backed round

Southampton, UK-based start-up Curve Therapeutics has completed a £40.5 million ($51 million) in Series A financing for its drug discovery platform that enables drug scree

News

Study rings warning bell over cancer therapy access in UK

Studies have suggested that cancer survival rates in the UK are lagging behind other countries by around 10 to 15 years because of lower rates of chemotherapy and radiothe

News

AI improves adenoma detection in colonoscopies

An artificial intelligence-powered computer-aided detection (CAD) system developed by Israeli medtech company Magentiq-Eye has been shown to improve detection rates for ad

News

After Roche’s exit, Blueprint passes Gavreto on to Rigel

Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug

News

Regeneron set for August FDA decision on BCMA bispecific

Regeneron’s bid to join the market for BCMA-targeted bispecific antibodies for multiple myeloma is nearing a conclusion, with the FDA starting a priority review of its lin

Janux plans $200m offer on back of prostate cancer readout

UK biotech Curve swings £40.5m in Pfizer-backed round

Study rings warning bell over cancer therapy access in UK

AI improves adenoma detection in colonoscopies

After Roche’s exit, Blueprint passes Gavreto on to Rigel

Regeneron set for August FDA decision on BCMA bispecific

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

News

Editor's Picks